High‐risk (HR) human papillomavirus (HPV) prevalence has been shown to correlate well
with cervical cancer incidence rates. Our study aimed to estimate the prevalence of HR‐HPV …

Background The high cost and insufficient supply of human papillomavirus (HPV) vaccines
have slowed the pace of controlling cervical cancer. A phase III clinical trial was conducted …

Prophylactic vaccination against HPV 16 and 18 has the potential for effective prevention of
high-grade precancer (cervical intraepithelial neoplasia [CIN)] 2/3) and ICC caused by these …

Infection with the human papillomavirus (HPV) is one of the most common sexually
transmitted infections and causes virtually all cervical cancer globally. The recent …

Summary Background This Escherichia coli-produced bivalent HPV 16 and 18 vaccine was
well tolerated and effective against HPV 16 and 18 associated high-grade genital lesions …

Cellular response to estrogen is mediated both by estrogen receptor (ER) binding to
estrogen response element (ERE) and by non-nuclear actions like activation of signal …

Twenty-six bacterial strains that had demonstrated antagonism to some fungal and bacterial
pathogens were evaluated for their ability to inhibit Meloidogyne incognita Kofoid & White …

Epidemiological studies have demonstrated that type 2 diabetes mellitus (T2DM) and
hyperinsulinemia are associated closely with endometrial carcinoma risk, although the …

Background: Pelvic lymph node metastasis (LNM) is an important prognostic factor in
cervical cancer. Cervical squamous cell carcinoma accounts for approximately 75–80% of …

Background Tumors with different gene expression develop and progress in different ways.
To deepen our understanding of the progression in endometrial cancer, and provide a …